Bogdana asked to discontinue Cholestaway cholesterol-lowering ad claims by NAD.
This article was originally published in The Tan Sheet
Executive Summary
BOGDANA ADVISED TO HALT CHOLESTAWAY CHOLESTEROL-LOWERING AD CLAIMS by the National Advertising Division of the Council of Better Business Bureaus. In a recent case report, the advertising watchdog group recommended that an infomercial on Cholestaway be "discontinued" because the company did not substantiate claims that the dietary supplement drastically reduces cholesterol levels. NAD also suggested that future advertising include "substantial modifications" so that the claims "more accurately reflect the extremely limited nature and extent of the substantiation provided to NAD."